Federica Pecci

Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non–Small-Cell Lung Cancer

Biagio Ricciuti, Giuseppe Lamberti, Sreekar Reddy Puchala et al. · Journal of Clinical Oncology · 2024 · 123 citations · Full text

Medicine, Immunology, Oncology +17

High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients

Luca Cantini, Federica Pecci, Daan P. Hurkmans et al. · European Journal of Cancer · 2020 · 113 citations · Full text

Medicine, Oncology, Pharmacology +15

Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRASG12D-mutated non-small-cell lung cancer

Biagio Ricciuti, Joao V. Alessi, Arielle Elkrief et al. · Annals of Oncology · 2022 · 101 citations · Full text

Medicine, Molecular Genetics, Oncology +14

Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC

Joao V. Alessi, Arielle Elkrief, Biagio Ricciuti et al. · Journal of Thoracic Oncology · 2023 · 91 citations · Full text

Medicine, Immunology, Oncology +16

Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario

Luca Cantini, Giulia Mentrasti, Gian Luigi Russo et al. · ESMO Open · 2022 · 65 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16